Therefore, it is possible that the TGFα-EGFR signaling axis promotes cancer cell proliferation, invasion, and metastasis, all of which drive the aggressiveness of TNBC and lead to poor response to EGFR inhibitors. This evidence concerns the gene EGFR and cancer.